1.
ERJ Open Res
; 10(1)2024 Jan.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38410709
RESUMEN
Articular manifestations should be screened before and during anti-IL-5/5R biologic treatment in severe asthma. Rigorous multidisciplinary team discussion should be carried out to assess the risk-benefit balance of withholding effective treatment. https://bit.ly/3vfPn4k.